A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Clinical trial NCT02624947 · COMPLETED

Trial details

NCT number: NCT02624947
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2015-12-01
Primary completion: 2018-12-28
Enrollment: 4636

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.